Scribe Biosciences Awarded a NIH Grant for High Throughput, Single-Cell Antibody Discovery
San Francisco, CA – August 10, 2023, Scribe Biosciences, a company developing technologies to study functional cell to cell interactions in a microenvironment, has announced it has received a NIH grant through the National Institute of Allergy and Infectious Disease for $300,000 to develop a method for large scale, single-cell functional screening workflow for antibody discovery. This award will help to accelerate the development of the MOD (Microenvironment on Demand) platform for plasma B cell functional assays for antibody discovery.
